Kinnate Biopharma has a total of 135 patents globally, out of which 9 have been granted. Of these 135 patents, more than 90% patents are active. The United States of America is where Kinnate Biopharma has filed the maximum number of patents, followed by China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kinnate Biopharma.
Kinnate Biopharma was founded in 2018. Kinnate Biopharma creates precision oncology medications to treat patients whose tumours have been identified through genomic analysis. The business makes use of its extensive expertise in translational research, patient-driven precision medicine, and structure-based medication discovery.
Do read about some of the most popular patents of Kinnate Biopharma which have been covered by us in this article and also you can find Kinnate Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kinnate Biopharma patent portfolio.
How many patents does Kinnate Biopharma have?
Kinnate Biopharma has a total of 135 patents globally. These patents belong to 23 unique patent families. Out of 135 patents, 122 patents are active.
How Many Patents did Kinnate Biopharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Kinnate Biopharma Applications Filed | Kinnate Biopharma Patents Granted |
| 2023 | 6 | 1 |
| 2022 | 32 | 5 |
| 2021 | 31 | 3 |
| 2020 | 51 | – |
| 2019 | 15 | – |
How many Kinnate Biopharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Kinnate Biopharma File in Different Countries?
Countries in which Kinnate Biopharma Filed Patents
| Country | Patent |
| United States Of America | 18 |
| China | 11 |
| Europe | 10 |
| Hong Kong (S.A.R.) | 10 |
| Taiwan | 9 |
| Canada | 9 |
| Australia | 9 |
| Argentina | 6 |
| Mexico | 4 |
| Brazil | 4 |
| Singapore | 4 |
| Israel | 4 |
| New Zealand | 3 |
| India | 2 |
| Chile | 2 |
| South Africa | 2 |
| Colombia | 2 |
| Indonesia | 2 |
| Korea (South) | 1 |
Where are Research Centers of Kinnate Biopharma Patents Located?
10 Best Kinnate Biopharma Patents
WO2020006497A1 is the most popular patent in the Kinnate Biopharma portfolio. It has received 12 citations so far from company like Incyte Corporation.
Below is the list of 10 most cited patents of Kinnate Biopharma:
| Publication Number | Citation Count |
| WO2020006497A1 | 12 |
| WO2020198058A1 | 10 |
| WO2021081375A1 | 6 |
| WO2019213403A1 | 6 |
| WO2020236524A1 | 5 |
| WO2021011796A1 | 5 |
| US10927111B2 | 4 |
| WO2020227020A1 | 4 |
| WO2021138215A1 | 4 |
| US11098031B1 | 3 |
What are Kinnate Biopharma key innovation segments?
What Technologies are Covered by Kinnate Biopharma?
The chart below distributes patents filed by Kinnate Biopharma